George A. Doherty
53Patents
14h-index
91Co-inventors
87Inventor score
Filing activity: Aug 14, 2000 → Jan 19, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8563735B2 | Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | Chemistry; Metallurgy | 70 | Active |
| US8546399B2 | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases | Emerging Cross-Sectional Technologies | 57 | Active |
| US8586754B2 | BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | Chemistry; Metallurgy | 55 | Active |
| US8557983B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 40 | Active |
| US8580794B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 35 | Active |
| US6420418B1 | Heterocycle amides as cell adhesion inhibitors | Human Necessities | 22 | Expired |
| US7605171B2 | (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists | Chemistry; Metallurgy | 20 | Expired |
| US8952157B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Emerging Cross-Sectional Technologies | 19 | Active |
| US7309721B2 | Aminoalkylphosphonates and related compounds as Edg receptor agonists | Chemistry; Metallurgy | 18 | Expired |
| US7351725B2 | N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists | Chemistry; Metallurgy | 17 | Expired |
| US9029404B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 16 | Active |
| US9034875B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 16 | Active |
| US9174982B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Emerging Cross-Sectional Technologies | 15 | Active |
| US7220734B2 | 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists | Chemistry; Metallurgy | 14 | Expired |
| US7479504B2 | Edg receptor agonists | Chemistry; Metallurgy | 13 | Expired |
| US9045420B2 | Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | Chemistry; Metallurgy | 9 | Active |
| US9073855B2 | BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases | Chemistry; Metallurgy | 9 | Active |
| US9303025B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Emerging Cross-Sectional Technologies | 9 | Active |
| US9072748B2 | BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | Chemistry; Metallurgy | 9 | Active |
| US9125913B2 | Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | Chemistry; Metallurgy | 8 | Active |
| US8940737B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 7 | Active |
| US6943180B2 | Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors | Chemistry; Metallurgy | 6 | Expired |
| US8524702B2 | Substituted benzoazepines as toll-like receptor modulators | Chemistry; Metallurgy | 5 | Active |
| US8044069B2 | Compounds as calcium channel blockers | Chemistry; Metallurgy | 5 | Active |
| US8975398B2 | NAMPT inhibitors | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.